Scientific research on cannabis reached new heights in 2022
More than 4,300 cannabis studies were published worldwide in the last 12 months.
24 results for “2022”
More than 4,300 cannabis studies were published worldwide in the last 12 months.
From groundbreaking studies to patient perspectives, here’s what happened in the world of UK cannabis (and beyond) in 2022
The majority of people in Europe now live in countries with some form of access to medical cannabis products, says a new report.
Take a look at what’s on during Medical Cannabis Awareness Week.
The night saw 30 winners – from best CBD influencer and social media campaign, to best pet range and sexual wellness brand.
The Good Level team pick a few of their favourite CBD gummies on the market right now.
Grow Pharma has set out its plans for the year ahead.
We explore the myriad of ways CBD could help you have a healthy 2022.
Dr Anthony Ordman explains how cannabis medicines could offer relief for back pain and the best dosage techniques
Is chronic pain, interrupted sleep and other debilitating symptoms affecting your ability to live well?
A new report has been published by the London Cannabis Legalisation Commission
The Department of Health has reached an agreement to continue the supply of Bedrocan oils
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
Two years on from the legalisation of medical cannabis in Ukraine, patients have received the first legal prescriptions for cannabis-based medicines.
The guide aims to help patients travel safely, confidently, and within the law.
The party has passed a motion that aims to protect patients from discrimination related to their use of prescribed cannabis medicines.
The case highlights the need for clear and consistent guidance on driving when prescribed medical cannabis.
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
Lab studies find that a combination of THC and CBD kills ovarian cancer cells without harming healthy cells
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains, and the dramatic swing towards higher THC products.
A new review highlights significant gaps in the evidence for medical cannabis, but other researchers say it may not present a balanced picture.
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? […]
We unpack the science behind the ECS and its significance in a range of chronic conditions.
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.